Stocks
Stryker Financial Statements (SYK) |
||||||||||
| Strykersmart-lab.ru | % | 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 11.02.2021 | 11.02.2022 | 31.12.2022 | 10.02.2023 | 14.02.2024 | 30.10.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 14 351 | 17 108 | 18 449 | 20 498 | 21 832 | ||||
| Operating Income, bln rub | 2 223 | 2 584 | 2 841 | 3 888 | 4 379 | |||||
| EBITDA, bln rub | ? | 3 755 | 4 646 | 4 536 | 5 160 | 4 798 | ||||
| Net profit, bln rub | ? | 1 599 | 1 994 | 2 358 | 3 165 | 3 318 | ||||
| OCF, bln rub | ? | 3 277 | 3 263 | 2 624 | 2 624 | 3 711 | 2 107 | |||
| CAPEX, bln rub | ? | 487.0 | 525.0 | 588.0 | 588.0 | 575.0 | 322.0 | |||
| FCF, bln rub | ? | 2 790 | 2 738 | 2 036 | 2 036 | 3 136 | 1 785 | |||
| Dividend payout, bln rub | 863.0 | 950.0 | 1 051 | 1 051 | 1 139 | 610.0 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| Dividend payout ratio, % | 54.0% | 47.6% | 44.6% | 36.0% | 18.4% | |||||
| OPEX, bln rub | 6 817 | 8 281 | 8 536 | 9 209 | 9 081 | |||||
| Cost of production, bln rub | 5 294 | 6 140 | 6 871 | 7 440 | 8 058 | |||||
| R&D, bln rub | 984.0 | 1 235 | 1 454 | 1 388 | 1 469 | |||||
| Interest expenses, bln rub | 315.0 | 337.0 | 158.0 | 356.0 | 0.000 | |||||
| Assets, bln rub | 34 330 | 34 631 | 36 884 | 36 884 | 39 912 | 43 833 | ||||
| Net Assets, bln rub | ? | 13 084 | 14 877 | 16 616 | 16 616 | 18 593 | 20 149 | |||
| Debt, bln rub | 13 230 | 12 472 | 11 857 | 13 048 | 12 995 | 15 484 | ||||
| Cash, bln rub | 3 024 | 3 019 | 1 928 | 1 928 | 3 053 | 4 684 | ||||
| Net debt, bln rub | 10 206 | 9 453 | 9 929 | 11 120 | 9 942 | 10 800 | ||||
| Ordinary share price, rub | 245.0 | 267.4 | 244.5 | 244.5 | 299.5 | 270.0 | ||||
| Number of ordinary shares, mln | 375.5 | 377.0 | 378.2 | 379.6 | 381.1 | |||||
| Market cap, bln rub | 92 013 | 100 817 | 0 | 92 466 | 113 675 | 102 897 | ||||
| EV, bln rub | ? | 102 219 | 110 270 | 9 929 | 103 586 | 123 617 | 113 697 | |||
| Book value, bln rub | -5 248 | -2 881 | 16 616 | -3 149 | -1 243 | -1 187 | ||||
| EPS, rub | ? | 4.26 | 5.29 | 6.23 | 8.34 | 8.71 | ||||
| FCF/share, rub | 7.43 | 7.26 | 5.38 | 8.26 | 4.68 | |||||
| BV/share, rub | -14.0 | -7.64 | -8.33 | -3.27 | -3.11 | |||||
| EBITDA margin, % | ? | 26.2% | 27.2% | 24.6% | 25.2% | 22.0% | ||||
| Net margin, % | ? | 11.1% | 11.7% | 12.8% | 15.4% | 15.2% | ||||
| FCF yield, % | ? | 3.03% | 2.72% | 0.00% | 2.20% | 2.76% | 1.73% | |||
| ROE, % | ? | 12.2% | 13.4% | 0.00% | 14.2% | 17.0% | 16.5% | |||
| ROA, % | ? | 4.66% | 5.76% | 0.00% | 6.39% | 7.93% | 7.57% | |||
| P/E | ? | 57.5 | 50.6 | 39.2 | 35.9 | 31.0 | ||||
| P/FCF | 33.0 | 36.8 | 0.00 | 45.4 | 36.2 | 57.6 | ||||
| P/S | ? | 6.41 | 5.89 | 5.01 | 5.55 | 4.71 | ||||
| P/BV | ? | -17.5 | -35.0 | 0.00 | -29.4 | -91.5 | -86.7 | |||
| EV/EBITDA | ? | 27.2 | 23.7 | 22.8 | 24.0 | 23.7 | ||||
| Debt/EBITDA | 2.72 | 2.03 | 2.45 | 1.93 | 2.25 | |||||
| R&D/CAPEX, % | 202.1% | 235.2% | 0.00% | 247.3% | 241.4% | 456.2% | ||||
| CAPEX/Revenue, % | 3.39% | 3.07% | 3.19% | 2.81% | 1.47% | |||||
| Stryker shareholders | ||||||||||
